Abstract:Pituitary adenomas, including prolactinomas and growth hormone (GH)-secreting adenomas, are common intracranial tumors in premenopausal women. Few studies have systematically documented the profile of these tumors in premenopausal women in China. Herein, we analyzed the clinical features and prognostic factors of 132 prolactinomas and 39 growth hormone-secreting adenomas treated by transsphenoidal surgery in Chinese premenopausal women. Patients with prolactinomas had smaller tumors (12 mm), higher preoperative prolactin levels (181.9 μg/L), and were younger (28 years) than those with GH-secreting adenomas or with other types of pituitary adenomas. The preoperative level of prolactin positively correlated with tumor size (r = 0.247, P = 0.005) and negatively correlated with age (r = -0.257, P = 0.003) in patients with prolactinomas. The diagnostic cut-off value for the preoperative level of prolactin was 112.2 μg/L with an area under the curve (AUC) of 0.854, a sensitivity of 78%, a specificity of 83%, a positive predictive value (PPV) of 73%, and a negative predictive value (NPV) of 86%. The postoperative remission rate of patients with prolactinomas was 60.7%. Tumor size, preoperative prolactin level, prolactin level on day 1 postsurgery, the postoperative prolactin reduction rate, and the tumor invasiveness were correlated with postoperative remission. However, the predictive factor of positive outcome was only low prolactin level on day 1 postsurgery [odds ratio (OR) = 0.931; 95% confidence interval (CI) = 0.883-0.981] in patients with prolactinomas, with a cut-off value of 20.49 μg/L (AUC: 0.950; sensitivity: 88%; specificity: 95%; PPV: 98%; NPV: 76%) based on logistic regression and receiver-operator characteristic (ROC) analysis. Patients with GH-secreting adenoma had a higher preoperative level of GH (14.3 μg/L), larger tumors (22.5 mm), and were older (41 years) than patients with prolactinoma or with other types of pituitary adenomas. The diagnostic cut-off value for the preoperative level of GH was 2.6 μg/L (AUC: 0.809; sensitivity: 77%; specificity: 83%; PPV: 36%; NPV: 97%), and the postoperative remission rate was 60.7%. Thus, we can conclude that the clinical characteristics and outcomes of prolactinomas and GH-secreting adenomas in premenopausal women were not precisely the same as those in patients with general pituitary adenoma. Prolac tinoma should be suspected in premenopausal women with a prolactin level greater than 112.2 μg/L. A GH level greater than 2.6 μg/L is highly suggestive of GH-secreting adenomas. A prolactin level less than 20.49 μg/L on day 1 postsurgery is a strong independent predictor of remission in Chinese premenopausal women with prolactinoma.

Prelimilary Study on MRI Findings of Prolactinomas in Male

Comparative Analysis and Clinical Application of Serum PRL and MRI Scan on Pituitary Prolactinoma

The Diagnostic Value of Conventional MRI Combined With Diffusion‐Weighted Imaging in Microprolactinomas

Diagnostic Value of MRI in Pituitary Microadenoma

Application of Contrast-Enhanced 3-Dimensional T2-Weighted Volume Isotropic Turbo Spin Echo Acquisition Sequence in the Diagnosis of Prolactin-Secreting Pituitary Microadenomas

Experience in the Treatment of Male Prolactinomas: A Single-Center, 10-Year Retrospective Study.

A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomas

MRI Diagnosis and Differential Diagnosis of Uncommon Diseases of Pituitary Gland

Typical Morphological Characteristics of the Immunohistochemistrical Subtypes of Pituitary Microadenomas: A dual center study

Clinical diagnosis and management of pituitary incidentalomas

Clinical characteristics and prognostic factors of prolactinomas and growth hormone-secreting adenomas in premenopausal women in China

The Study of Dynamic Contrast Enhancement MRI in the Diagnosis of Pituitary Microadenoma

Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study

Prolactinoma combined with Rathke s cleft cyst:a report of three case and literature review

Pituitary Prolactinoma Imaged by Tc-99m-Sestamibi Spect/Ct in A Multiple Endocrine Neoplasia Type 1 Patient

Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases.

Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia?

[Increased T1 signal of the residual normal anterior pituitary gland following medical treatment of pituitary prolactinoma]

An Evaluation of MRI in the Diagnosis of Primary Adrenal Tumors

MR Imaging Analysis of Posterior Pituitary in Patients with Pituitary Adenoma.

Pre- and Postoperative Magnetic Resonance Imaging Comparative Studies of Pituitary Tissues Following Transsphenoidal Resection of Pituitary Macroadenomas